INTRODUCTION {#SEC1}
============

A fine balance between DNA damage and repair is critical for proper nervous system development and function ([@B1],[@B2]). Multiple defense mechanisms are activated to repair damaged DNA or remove the impaired neural cells bearing DNA damage ([@B3]). Defects in these defense mechanisms can disrupt brain development and function, leading to human genetic disorders with neurological phenotypes, such as Ataxia Telangiectasia (A-T; caused by mutations in the gene encoding Ataxia telangiectasia mutated, *ATM*, mutations), Spinocerebellar ataxia with axonal neuropathy 1 (SCAN1; Tyrosyl-DNA phosphodiesterase 1, *TDP1*, mutations), Ataxia with oculomotor apraxia and hypoalbuminemia (AOA1; Aprataxin, *APTX*, mutations) and Ataxia oculomotor apraxia 4 (AOA4; Polynucleotide kinase phosphatase, *PNKP*, mutations, which is also responsible for Microcephaly, seizures and developmental delay, MCSZ) ([@B1],[@B2],[@B4],[@B5]). A common neurological feature of these genetic disorders is progressive cerebellar ataxia, although these repair proteins are involved in different mechanisms of DNA damage repair. ATM is a protein kinase activated immediately upon DNA strand breaks to regulate DNA damage responses, including cell cycle arrest and apoptosis, whereas TDP1, APTX and PNKP are key enzymes that process broken DNA strand ends for proper ligation ([@B1],[@B2],[@B4],[@B6]). Despite the association between cerebellar ataxia and defective DNA damage repair, the detailed molecular mechanisms, as well as the progression of ataxia in particular, are not fully understood due to the limited availability of human tissues from the early stage of cerebellar ataxia.

Previously, X-ray repair cross complementing 1 (*Xrcc1*) inactivation during neurodevelopment in the mouse was studied to understand the connection between defective DNA single-strand break (SSB) repair and neural abnormalities ([@B7]). DNA damage accumulates throughout the brains of *Xrcc1* conditional knockout animals, yet restricted neural abnormalities such as a selective *p53*-dependent loss of cerebellar interneurons and sporadic seizures likely due to hippocampal defects were observed ([@B7]). XRCC1 is a scaffold protein that binds to multiple DNA SSB repair and Base Excision Repair (BER) factors, including Apurinic/apyrimidinic \[AP\] endonuclease 1 (APEX1), TDP1, APTX DNA ligase III (LIG3), Poly\[ADP-ribose\] polymerase 1 (PARP1) and DNA polymerase β (POLB), and brings these binding proteins to the sites of DNA damage to facilitate precise damage repair ([@B6],[@B8],[@B9]). As XRCC1 involvement in DNA damage repair is reflected by the function of these binding factors, one or a combination of binding partners may be responsible for neurological abnormalities observed in the *Xrcc1* conditional knockout animal. However, the neurological phenotypes, particularly cerebellar defects, resulting from *Xrcc1* inactivation were not fully replicated by inactivation of these XRCC1 binding proteins, such as *Aptx, Lig3, Tdp1, Apex1* and *Pnkp*, in the nervous system ([@B10]). Interestingly, *Parp1* inactivation, which by itself does not alter the cerebellar interneuron population, rescued the loss of cerebellar interneurons in *Xrcc1* conditional knockout animals ([@B9],[@B16]).

Here, we examined whether *Polb* inactivation during neurodevelopment is related to the XRCC1-dependent neurological phenotypes. POLB performs two enzymatic activities: it adds one nucleotide to the 3′ end of DNA strands as a DNA polymerase, and it removes 5′ sugar phosphates as a deoxyribose phosphate lyase during the repair of AP sites in BER that corrects DNA base damage ([@B17]). BER also could regulate gene expression by participating in the cycle of DNA demethylation ([@B18]). We demonstrate that conditional inactivation of *Polb* in the nervous system does not result in substantial neural abnormalities. However, double knockout animals deficient for *Polb* and *Atm* displayed severe ataxia in the absence of significant neuropathology, but with reduced cerebellar expression of Inositol 1,4,5-triphosphate receptor 1 (*Itpr1*), a gene associated with cerebellar ataxia in humans ([@B19],[@B20]), which likely resulted from misregulated cytosine methylation. These findings suggest that a reduction of *Itpr1* could be one of contributors to the progression of cerebellar ataxia caused by genomic instability.

MATERIALS AND METHODS {#SEC2}
=====================

Animals {#SEC2-1}
-------

Animals harboring a floxed *DNA polymerase β* gene (*Polb*) (B6.129P2-Polb^tm1Rsky^/J, stock no: 009154) were purchased from the Jackson Laboratory (Bar Harbor, ME, USA). As germline deletion was embryonic lethal ([@B21]), exon 1 of *Polb* flanked by *LoxP* sites was targeted by crossed with the *Nestin-Cre* line \[B6.Cg-Tg(Nes-cre)1Kln/J, stock no: 003771\] to restrict *Polb* inactivation in the nervous system during development, yielding *Polb ^LoxP/LoxP^; Nestin-Cre* (indicated as *Polb* cKO or *Polb ^Nes-Cre^*, hereafter) animals. As no phenotypic difference was observed between male and female mice, both sexes were used for analyses. *Xrcc1* conditional knockout (*Xrcc1^Nes-Cre^*) and *Atm* knockout animals were described before ([@B7],[@B13]). All irradiated (Cs^137^) tissue samples were prepared at St. Jude Children\'s Research Hospital (Memphis, TN, USA). The presence of a vaginal plug indicated as Embryonic day 0.5 (E0.5), and the day of birth was designated as postnatal day 0 (P0). All animals were housed in the Laboratory Animal Research Center of Ajou University Medical Center and maintained in accordance with the guidelines of the Institutional Animal Care and Use Committee. All procedures for animal use were approved by the committee.

Quantitative realtime PCR {#SEC2-2}
-------------------------

To assess the efficacy of gene deletion by *Cre* recombinase, the genomic DNA from the several brain areas of the adult mice were extracted. The exon 1 (targeted) and exon 14 (control) of the *Polβ* gene were measured by realtime polymerase chain reaction (PCR) method using a Qiagen system (Roto-Gene Q PCR machine and SYBR Green PCR kit, Qiagen, Hilden, Germany). The efficacy of gene deletion was calculated as a ratio between exon 1 and exon 14 measurements.

Western blot analysis {#SEC2-3}
---------------------

Tissue samples from two to three animals for each genotype were collected and snap frozen at various time points. Western blotting was performed as described previously with a slight modification ([@B7],[@B13]). The equal loading of samples was confirmed by antibodies against actin (1:2500, mouse; Santa Cruz Biotechnology, Dallas, TX, USA) or tubulin (1:40 000, mouse; a gift from Dr Sang Gyu Park) or by Ponceau-staining. The list of antibodies used for western blot analyses is presented in [Supplementary Materials and](#sup1){ref-type="supplementary-material"} Methods.

Histopathological analysis {#SEC2-4}
--------------------------

Histopathological analyses were performed as described previously ([@B7],[@B13]). Two to four embryos or brains for each genotype were collected and fixed at various time points. Nissl staining was performed via a routine procedure. Immunopositive signals were visualized using the VIP substrate kit (Vector Laboratories, Burlingame, CA, USA), or with fluorophore (FITC- or Cy3-) conjugated secondary antibodies (Jackson ImmunoResearch Laboratories, West Grove, PA, USA). Immunoreactive signals were enhanced with citric acid-based antigen retrieval as needed. For apoptosis analysis, a TUNEL assay using Apoptag (Chemicon, Temecula, CA, USA) was applied. The list of antibodies used for histopathological analyses is presented in [Supplementary Materials and](#sup1){ref-type="supplementary-material"} Methods.

Genomics analysis {#SEC2-5}
-----------------

Four analyses were performed to ascertain the genomic event underlying the observed ataxia in mutant mouse models. First, the RNAseq was performed with an assistance provided by DNA Link (Seoul, Korea). The reads were mapped with the Tophat aligner using the UCSC mouse mm10 genome (Genome Reference Consortium GRCm38), and the Cuffdiff program was used to screen for differentially expressed genes. Further functional annotation analysis was carried out with the DAVID Bioinformatics Resources (<https://david.ncifcrf.gov>). RNAseq data were also analyzed with another genomic analysis platform, StrandNGS (Strands Life Sciences, Bengaluru, India). All RNAseq data were normalized and filtered by expression levels. Genes that showed at least a 2-fold difference (5-fold difference for the further screening) in multiple comparisons after statistical evaluation, including analysis of variance (ANOVA) with a Bonferroni false-discovery rate correction, were selected and analyzed further by the pathway algorithm provided by StrandNGS using 627 publicly available signaling pathways. Second, DNA methylation was interrogated using mouse CpG Island Microarray (Agilent, Santa Clara, CA, USA) covering 15,342 CpG Islands (97,652 CpG probes) and the UCSC mm9 genome (NCBI Build 37) with a support from Genomictree (Daejeon, Korea). Fluorescence was scanned and the intensities calculated for data analysis, including per spot and per chip Lowess normalization, and fold differences were calculated with GeneSpring software and the Workbench program (Agilent Genomics). We further analyzed the lists of significant genes from the CpG Island Microarray analysis using publicly available web-based application, Venn diagram analysis (<http://bioinformatics.psb.ugent.be/webtools/Venn/>). Third, DNA methylation on the promoter region of *Itpr1* was assessed via DNA pyrosequencing with a support from Genomictree. CpG Island prediction was carried out using the web-based application, MethPrimer (<http://www.urogene.org/cgi-bin/methprimer/methprimer.cgi>) ([@B22]). The methylation percentage was calculated by the average degree of methylation at 1--7 CpG sites formulated in pyrosequencing. Fourth, the DNA sites with 5-hydroxymethylcytosine (5hmC) modification and their frequencies at a single-base resolution were further analyzed via the Reduced Representation Hydroxymethylation Profiling (RRHP) ([@B23]). The DNA library preparation and sequencing were performed by Zymo Research (Irvine, CA, USA). The RRHP reads and locations of 5hmC throughout the whole genome, particularly at the *Itpr1* gene, were visualized using the UCSC genome browser (<http://genome.ucsc.edu/cgi-bin/hgGateway>) and Integrative Genomics Viewer (<http://software.broadinstitute.org/software/igv/>). The lists of genes from genomic analyses were further examined with gene ontology enrichment analysis (<http://geneontology.org>, <http://pantherdb.org>, and <https://tools.dice-database.org/GOnet/>---which provides gene nodes colored by expression in various cell types/tissues including the cerebellum: Bgee DB \[<http://bgee.org>\] for the mouse).

ELISA and chemiluminescent assay {#SEC2-6}
--------------------------------

To measure percent 5-methylcytosine (5mC) and 5hmC DNA, denatured single-stranded DNA samples from the cerebral cortices and cerebella were either plated directly onto an ELISA plate for 5mC measurement or onto a 5hmC antibody-coated ELISA plate for 5hmC measurement according to the manufacturer\'s manual (Enzo Life Sciences, Farmingdale, NY, USA), and then the positive signals were measured at 405 nm. Each sample was prepared in triplicates, and these analyses were repeated twice. Percent 5mC and 5hmC were calculated by the equation provided in the manufacturer\'s manual.

The enzyme activities of DNMT1 and TET1 in the protein lysates from the cerebral cortices and cerebella were measured using chemiluminescent assay kits from BPS Bioscience (San Diego, CA, USA). The chemiluminescence signals were measured according to the manufacturer\'s protocol and then further normalized by protein quantity. Each sample was prepared in triplicates, and these analyses were repeated two times.

Image and statistical analyses {#SEC2-7}
------------------------------

Microscopy images and other digital images were composited using Photoshop software (Adobe, San Jose, CA, USA) and analyzed in ImageJ (NIH, USA) with the measuring and densitometry function. All statistical analyses were performed using Prism software (GraphPad Software, San Diego, CA, USA). A *P*-value of \<0.05 was considered significant.

The complete description of materials and methods is presented in the Supplementary Data; [Supplementary Materials and](#sup1){ref-type="supplementary-material"} Methods.

RESULTS {#SEC3}
=======

*Polb* inactivation during neurogenesis does not affect overall brain development {#SEC3-1}
---------------------------------------------------------------------------------

Germline deletion of *Polb* in mice is embryonic lethal and induces neural apoptosis, particularly in the ganglionic eminence (GE) of the embryonic brain ([@B21],[@B24]). To circumvent embryonic lethality, *Polb* was selectively inactivated during neurogenesis in a *Nestin-Cre* line. The *Polb^Nes-Cre^* animals were born at an expected Mendelian ratio and had a shorter life span without any noticeable neurological or behavioral abnormities (Figure [1A](#F1){ref-type="fig"}). The *Polb* gene and POLB protein were absent from brain tissues of adult *Polb^Nes-Cre^* mice, whereas expression of XRCC1 and APEX1, which are related DNA damage repair proteins ([@B9]), was not affected in these mutant brains ([Supplementary Figure S1A and B](#sup1){ref-type="supplementary-material"}). Furthermore, neuron, interneuron and glial cell (astrocytes and oligodendrocytes) populations in brains of adult *Polb^Nes-Cre^* animals were comparable to those in control animals (Figure [1B](#F1){ref-type="fig"}--[D](#F1){ref-type="fig"}). Importantly, the cerebellar defects found in the *Xrcc1^Nes-Cre^*animals, such as cerebellar interneuron loss ([@B7]), were not observed in the *Polb^Nes-Cre^* animals. Particularly parvalbumin-positive (Par+) interneurons were intact in the molecular layer of the *Polb^Nes-Cre^* cerebellum, and the corresponding expression levels of cerebellar parvalbumin did not differ from those of the controls (Figures [1B](#F1){ref-type="fig"}--[D](#F1){ref-type="fig"} and [3](#F3){ref-type="fig"}), suggesting that *Polb* inactivation did not contribute to the neurological defects, especially cerebellar defects resulting from *Xrcc1* deficiency.

![*Polb* inactivation during neurogenesis does not affect overall brain development. (**A**) Kaplan--Meier survival curve. *Polb* inactivation in the nervous system (*Polb^Nes-Cre^*) of the mouse was associated with a shorter life span than in wild-type animals, yet it was longer than that in *Xrcc1* conditional (*Xrcc1^Nes-Cre^*; *Xrcc1* inactivation in the nervous system using a *Nestin-Cre* line) animals. *N* indicates the number of animals observed for the analysis. M/S, median survival days. (**B**) Histopathological analysis of adult (10 months old \[10 m\]) cerebella and cerebral cortices (sagittal plane). There was no difference between the control (Ctrl) and *Polb^Nes-Cre^* brains, except for fewer parvalbumin-positive interneurons and axons (red arrow heads) in the *Polb^Nes-Cre^* cerebral cortex. There was also no sign of cerebellar interneuron loss (yellow arrow heads) in the *Polb^Nes-Cre^* cerebellum, which is one of the major neural defects found in the *Xrcc1* null cerebellum ([@B7]). CA2, Cornu ammonis area 2 of the hippocampus; DG, Dentate gyrus of the hippocampus; OB, Olfactory bulb; CC, Corpus Callosum; Mo, Molecular layer in the cerebellum; Pur, Purkinje cell layer in the cerebellum; Gr, Granule cell layer in the cerebellum. (**C** and **D**) Western blots (*C*) and quantification (*D*) analyses of several neural markers in the cerebral cortices and cerebella of mice at 6 months (6 m) and 1 year (1 y) of age, which show no defects in the *Polb^Nes-Cre^* animals except for reduced parvalbumin in the *Polb^Nes-Cre^* cerebral cortices, not in the cerebella. The protein levels of indicated markers were measured using ImageJ (densitometry) and were normalized to those of tubulin (*D*). *N* = 3. All bars indicate mean ± SEM; \*, *P* \< 0.05. Neuronal marker, (NeuN); Astrocyte marker, (GFAP); Oligodendrocyte marker, (NG2, CNPase, Olig2); Interneuron/specialized neuronal marker, (GAD, Somatostatin, Calbindin, Calretinin, Parvalbumin). (**E** and **F**) Apoptosis detected by TUNEL (Green staining, *E*) and corresponding quantification (*F*) in the lateral, medial and caudal Ganglionic Eminence at E15.5 (coronal plane). Neural apoptosis was found only in the *Polb^Nes-Cre^* Ganglionic Eminence, which disappeared in an *Atm*^−/−^ background. TUNEL positivity was measured using ImageJ in the demarcated areas (white dotted lines) from multiple embryonic sections (F). Counter staining: Propidium Iodide (PI). *N* = 4 (Ctrl), *N* = 3 each (each genetic backgrounds). All bars indicate mean ± SEM; \*\*\*\*, *P* \< 0.001; \*\*\*, *P* \< 0.005. (**G** and **H**) DNA damage visualized as γ-H2AX foci formation (red punctate staining, (G) and corresponding quantification (H) in the lateral, medial and caudal Ganglionic Eminence at E15.5 (coronal plane). The amounts of DNA damage are similar in the *Polb^Nes-Cre^* and *Polb^Nes-Cre^Atm^−/−^* Ganglionic Eminence, and were negligible in control (Ctrl) and *Atm^−/−^* embryos. γ-H2AX foci were measured using ImageJ in several 150-μm^2^ areas from multiple embryonic sections (H). Counter staining: 4′,6-diamidino-2-phenylindole (DAPI). *N* = 4 (Ctrl), 3 (*Atm^−/−^*, *Polb^Nes-Cre^*) and 2 (*Polb^Nes-Cre^Atm^−/−^*). All bars indicate mean ± SEM; \*\*\*\*, *P* \< 0.001; NS, not significant.](gkaa140fig1){#F1}

By contrast, the cerebral cortices of *Polb^Nes-Cre^* animals exhibited a selective reduction of Par+ interneurons (Figure [1B](#F1){ref-type="fig"}--[D](#F1){ref-type="fig"}). As Par+ cortical interneurons originate from the GE ([@B25]), we examined *Polb^Nes-Cre^* animals during embryogenesis. For this analysis, the *Polb^Nes-Cre^Atm^−/−^* embryos were also included in order to investigate ATM involvement in this neurological context. Proliferation and maturation in the brains of *Atm^−/−^, Polb^Nes-Cre^* and *Polb^Nes-Cre^Atm^−/−^* embryos were similar to those in control embryos ([Supplementary Figure S1C](#sup1){ref-type="supplementary-material"}). Signs of neural apoptosis were found mainly in the GE of the *Polb^Nes-Cre^* embryonic brain, similarly to previous reports ([@B24],[@B26]), which was disappeared in an *Atm*-null background (Figure [1E](#F1){ref-type="fig"} and [F](#F1){ref-type="fig"}; [Supplementary Figure S1D](#sup1){ref-type="supplementary-material"}). However the amounts of DNA damage as measured by the formation of γ-H2AX foci in all three GE subdivisions were similar between the *Polb^Nes-Cre^* and *Polb^Nes-Cre^Atm^−/−^* embryos, and the sign of DNA damage was negligible in the control and *Atm^−/−^* embryonic GEs (Figure [1G](#F1){ref-type="fig"} and [H](#F1){ref-type="fig"}; [Supplementary Figure S2A](#sup1){ref-type="supplementary-material"}). These data suggest that *Polb* inactivation results in DNA damage, and that ATM is involved in neural apoptosis triggered by DNA damage during neurogenesis, as previously demonstrated ([@B27]). It is likely that apoptosis confined to the GE resulted in reduced Par+ neurons in the *Polb^Nes-Cre^* cerebral cortex. This loss of cortical Par+ interneurons and apoptosis in the GE was not apparent in the *Xrcc1^Nes-Cre^* brain ([@B7]), implicating a complex involvement of DNA damage repair factors in brain development and function.

*Polb* deficiency causes chronic DNA damage in the brain, and double inactivation of *Polb* and *Atm* results in severe ataxia {#SEC3-2}
------------------------------------------------------------------------------------------------------------------------------

Unexpectedly, double inactivation of *Polb* and *Atm* during neurogenesis resulted in severe ataxia which became apparent after 2 weeks of age. All *Polb* and *Atm* double knockout animals could not control hind limb movements and hold still, and these double knockout animals did not survive beyond ∼3--4 weeks, likely due to inanition (Figure [2A](#F2){ref-type="fig"}; [Supplementary Movie clip](#sup1){ref-type="supplementary-material"}). This neurological phenotype was similar to that observed in the *Xrcc1* and *Atm* double knockout animals ([@B13]). However, a thorough examination of the *Polb* and *Atm* double knockout brains did not reveal any neuropathological abnormalities, particularly in the cerebellum. The *Polb^Nes-Cre^Atm^−/−^* brains were grossly normal in size, with no alterations of neural population except for a reduction in cortical Par+ neurons comparable to that observed in the cerebral cortices of *Polb^Nes-Cre^* animals (Figure [2B](#F2){ref-type="fig"}--[D](#F2){ref-type="fig"}). Although *Atm* inactivation suppressed neural apoptosis in the *Polb* conditional knockout GE during embryogenesis (Figure [1E](#F1){ref-type="fig"} and [F](#F1){ref-type="fig"}), this was not sufficient enough to recover the maturation process of cortical Par+ neurons, which occur during postnatal development ([@B25]). Alternatively, interneuron progenitor cells in the *Polb^Nes-Cre^Atm^−/−^* GE, which would express parvalbumin in the mature cerebral cortex, could not restore their proliferative potential, as a similar observation reported previously ([@B28]).

![*Polb* and *Atm* double inactivation results in severe ataxia without significant neuropathological defects in the cerebellum. (**A**) Kaplan--Meier survival curve. The *Polb^Nes-Cre^Atm^−/−^* animals did not live beyond 3--4 weeks of age, similar to the *Xrcc1^Nes-Cre^Atm^−/−^* animals. *Polb/Atm* and *Xrcc1/Atm* double conditional knockout animals were both severely ataxic. *N* indicates the number of animals observed for the analysis. M/S, median survival days. (**B**) Gross view of the brains in different genetic backgrounds at postnatal day (P) 21. The red lines demarcate the cerebellum, which shows no difference in size. (**C** and **D**) Western blot analysis of several neural markers in the cerebral cortices and cerebella at P21 (C) and quantification analyses of neural markers (D). No abnormal expression was found in either *Polb^Nes-Cre^* or *Polb^Nes-Cre^Atm^−/−^* brains except for cortical parvalbumin (C). *Atm* deficiency was not sufficient to rescue reduced parvalbumin expression in the *Polb^Nes-Cre^* cerebral cortex. The protein levels of indicated neural markers were measured using ImageJ (densitometry) and were normalized to those of tubulin (*F*). *N* = 3. All bars indicate mean ± SEM; \*, *P* \< 0.05. (**E** and **F**) Histopathological analysis of the cerebellum at P21 (*E*) (sagittal and coronal planes). In the cerebella of *Polb^Nes-Cre^Atm^−/−^* animals that showed severe ataxia, the Purkinje cell layer detected by calbindin immunopositivity (quantified in *F*) is normally organized, and parvalbumin-(yellow arrowheads, quantified in D) and calretinin-positive interneurons are intact. Increased GFAP immunoreactivity (Bergmann glia) in the *Polb^Nes-Cre^* and *Polb^Nes-Cre^Atm^−/−^* cerebella is visible, which is a common feature among animal models of genomic instability. Interneurons in the molecular layer, Purkinje cells and granule cells were counted (D) in numerous 0.27-mm^2^ areas (0.07 mm^2^ for granule cells; Nissl staining \[*C*\]) of the matched cerebellar parts, which show no difference. Counter staining: methyl Green. *N* = 4 (Ctrl), *N* = 3 each (other genetic backgrounds). All bars indicate mean ± SEM; NS, not significant; Mo, Molecular layer; Gr, Granule cell layer; Pur, Purkinje cell layer. (**G**) ATM phosphorylation (ATM-p) was observed only in the *Polb* inactivated embryonic brain at E15.5 and in the *Polb* null cerebellum at 3 weeks (wks) of age. The red dots indicate mouse ATM phosphorylated at serine 1987. \* ionizing radiated (10Gy) murine thymus as a positive control. The blue line indicates a 100-kDa molecular weight marker.](gkaa140fig2){#F2}

To determine the cause of ataxia, we focused on the cerebella of *Polb^Nes-Cre^Atm^−/−^* animals. Continually induced DNA damage, visualized as the formation of nuclear γ-H2AX foci, was present at similar distributions and amounts in both *Polb* conditional knockout and *Polb^Nes-Cre^Atm^−/−^* brains during neurogenesis and in the brain ([Supplementary Figure S2A and B](#sup1){ref-type="supplementary-material"}). This endogenously induced DNA damage likely triggered ATM phosphorylation, particularly in the cerebellum (Figure [2G](#F2){ref-type="fig"}). Nevertheless, signs of apoptosis were not observed in the developing cerebella of the *Polb^Nes-Cre^* and *Polb^Nes-Cre^Atm^−/−^* embryos ([Supplementary Figure S1D](#sup1){ref-type="supplementary-material"}). There were comparable amounts of parvalbumin detected in the cerebella of mice from all four different genetic backgrounds (Figure [2C](#F2){ref-type="fig"} and [D](#F2){ref-type="fig"}); these originate from the ventricular zone of embryonic cerebellum ([Supplementary Figure S1C](#sup1){ref-type="supplementary-material"}) ([@B29]). Moreover, there were no signs of neuropathology related to ataxia in the *Polb^Nes-Cre^Atm^−/−^* cerebella, with similar cerebellar structures and neuronal populations, including Purkinje cells, granule cells, and cerebellar interneurons, as in the *Atm^−/−^* and *Polb^Nes-Cre^* cerebella (Figure [2E](#F2){ref-type="fig"} and [F](#F2){ref-type="fig"}; [Supplementary Figure S2C](#sup1){ref-type="supplementary-material"}). In a stark contrast to the *Polb^Nes-Cre^Atm^−/−^* cerebella, the *Xrcc1^Nes-Cre^Atm^−/−^* cerebella were smaller and less foliated than age-matched *Atm^−/−^* and *Xrcc1^Nes-Cre^* cerebella. Furthermore, the Purkinje cell layer was entirely disarrayed in the *Xrcc1^Nes-Cre^Atm^−/−^* cerebella (Figure [3A](#F3){ref-type="fig"} and [B](#F3){ref-type="fig"}), resulting in severe ataxia ([Supplementary Movie clip](#sup1){ref-type="supplementary-material"}) ([@B13]). In addition, Par+ interneurons, PAX2 positive interneurons and glutamic acid decarboxylase positive GABAergic neurons were not recovered in the *Atm* null background (Figure [3B](#F3){ref-type="fig"} and [C](#F3){ref-type="fig"}), indicating that cerebellar interneuron loss resulting from *Xrcc1* inactivation was *p53* dependent but *Atm* independent ([@B7]).

![*Atm* inactivation in the *Xrcc1^Nes-Cre^* brain results in abnormal cerebellum. (**A**) Gross view of the brains of mice from different genetic backgrounds (control, *Atm^−/−^*, *Xrcc1^Nes-Cre^*, *Xrcc1^Nes-Cre^Atm^−/−^*) at P15. The red lines demarcate the cerebellum. The size of the cerebellum was reduced in the *Xrcc1^Nes-Cre^Atm^−/-^* mice. OB, Olfactory bulb; CTX; Cerebral cortex; Ce, Cerebellum; Sp, Spinal cord. (**B**) Histopathological analysis of the cerebellum at P15. GAD (glutamate decarboxylase) immunoreactivity is for the GABAergic neuron network, and NF200 (neurofilament 200) immunoreactivity is for neurons. The *Xrcc1^Nes-Cre^Atm^−/−^* cerebella showed signs of interneuron loss (yellow arrows, parvalbumin positive interneurons; white arrows, GABAergic neurons) in the molecular layer, similarly to the *Xrcc1^Nes-Cre^* cerebella, suggesting that interneuron loss in *Xrcc1* deficiency is ATM independent and p53 dependent ([@B7]). Gr, Granule cell layer; Pur, Purkinje cell layer; MO, Molecular layer. (**C**) Histopathological analysis of the cerebella of *Atm^−/−^*, *Xrcc1^Nes-Cre^*, and *Xrcc1^Nes-Cre^Atm^−/−^* animals at P7 (sagittal plane), when the Purkinje cells are in a single-cell layer and foliation of all cerebellar lobules are noticeable. Nissl staining shows the overall structure of the cerebellar vermis. Calbindin immunoreactivity for the Purkinje cell layer, parvalbumin immunoreactivity for interneurons in the molecular layer and Purkinje cells, GABARa6 immunoreactivity for the granule cell layer, GFAP immunoreactivity for the Bergmann glia network, and PAX2 immunoreactivity for interneurons in the cerebellum are shown. The *Atm* null cerebellum was normal for the formation of Purkinje and granule cell layers and for the interneuron population. The *Xrcc1^Nes-Cre^* cerebellum also showed normal development except for fewer interneurons (PAX2-positive cells) as described before ([@B7]). However, the Purkinje cell layer was not properly organized in the *Xrcc1^Nes-Cre^Atm^−/−^* cerebellum, which was smaller and less foliated. Also, PAX2-positive interneurons were not rescued in the *Xrcc1^Nes-Cre^Atm^−/−^* cerebellum. Gr, Granule cell layer; EGL, External germinal layer; Pur, Purkinje cell layer.](gkaa140fig3){#F3}

*Itpr1* is the most differentially expressed gene in *Polb/Atm* and *Xrcc1/Atm* double knockout cerebella {#SEC3-3}
---------------------------------------------------------------------------------------------------------

As the *Polb^Nes-Cre^Atm^−/−^* cerebella appeared structurally normal, we next performed RNA sequencing (RNAseq) to identify genetic modifications contributing to the ataxia. Cerebellar samples from control, *Atm^−/−^*, *Polb^Nes-Cre^* and *Polb^Nes-Cre^Atm^−/−^* animals had similar genic regions overall ([Supplementary Figure S3A](#sup1){ref-type="supplementary-material"}), and robust data-mining analyses revealed small groups of genes that were differentially expressed in each of the genetic backgrounds studied (five genes in the *Polb^Nes-Cre^*, 31 in *Atm^−/−^*, 64 in *Polb^Nes-Cre^Atm^−/−^* and three in both *Polb^Nes-Cre^Atm^−/−^* and *Atm^−/−^*) (Figure [4A](#F4){ref-type="fig"}; [Supplementary Figure S3B](#sup1){ref-type="supplementary-material"}, their hierarchical analyses: [Supplementary Figure S3C-F](#sup1){ref-type="supplementary-material"}). The ontology and signaling analyses, using publicly and commercially available platforms, of these differentially expressed genes did not reveal any outcomes significantly related to progressive cerebellar ataxia in human genetic diseases. Next, a stringent and higher fold-difference filtering was applied to the 67 genes that were differentially expressed in the *Polb^Nes-Cre^Atm^−/−^* cerebellum, and 14 genes were retained (Figure [4A](#F4){ref-type="fig"}; [Supplementary Figure S3E and F](#sup1){ref-type="supplementary-material"}). Among these genes, only *Itpr1* and carbonic anhydrase 8 (*Car8*) are directly related to cerebellar ataxia in humans ([@B19],[@B20],[@B30]). Notably, *Itpr1* was the highest expressed gene in the control, *Atm^−/−^* and *Polb^Nes-Cre^* cerebella. Also this gene was the most downregulated in the *Polb^Nes-Cre^Atm^−/−^* cerebella (Figure [4A](#F4){ref-type="fig"} and [B](#F4){ref-type="fig"}).

![*Itpr1* expression is reduced the most in the cerebella of *Polb^Nes-Cre^Atm^−/−^* and *Xrcc1^Nes-Cre^Atm^−/−^* animals that show severe ataxia. (**A**) Hierarchical cluster analysis of cerebellar RNAseq data. The Venn diagram indicates the numbers of genes significantly and uniquely up- or downregulated in each mutant cerebellum. Hierarchical clustering of the top 14 genes among 44 upregulated and 23 downregulated genes unique to the *Polb^Nes-Cre^Atm^−/−^* cerebellum is shown. The color scale of the normalized expression values ranges from 0 (blue) to 12 (yellow) to 18 (red). The gene list also includes related human genetic disease information obtained from the public database (<http://omim.org> and <http://rarediseases.info.nih.gov>). The most differentially expressed gene in the *Polb^Nes-Cre^Atm^−/−^* cerebellum was *Itpr*1, compared with that in the control, *Atm^−/−^* and *Polb^Nes-Cre^* cerebella at 3 weeks of age. *ITPR1* mutations or deletions are responsible for Spinocerebellar ataxia 15/29 or Gillespie syndrome. (**B**) RNAseq profiling of *Itpr1* in the mouse cerebellum at 3 weeks of age; the *Itpr1* gene is located on chromosome 6 (Chr6) 108,213,083--108,551,116. The vertical lines in the gene structure indicate exons, and the zigzag lines indicate introns. The black peaks matched with exon locations represent the normalized RNAseq reading (*y*-axis scale, 0--1900), and these peaks are negligible in the *Polb^Nes-Cre^Atm^−/−^* cerebellum, indicating the reduction of *Itpr1* expression in this particular genetic background. (**C**) Immunostainings of ITPR1 and CAR8, which are highly and exclusively expressed in the Purkinje cell layer of the cerebellum (coronal plane). ITPR1 immunopositivity is almost absent in the *Polb^Nes-Cre^Atm^−/−^* cerebellum. Also reduced CAR8 staining is visible in the double knockout cerebellum. Mo, Molecular layer; Pur, Purkinje cell layer; Gr, Granule cell layer. (**D** and **E**) Western blots (D) and quantification (E) analyses for ITPR1, ITPR2, ITPR3 and CAR8 in the cerebral cortices and cerebella at 3 weeks of age. A dramatic reduction of ITPR1 is evident only in the *Polb^Nes-Cre^Atm^−/−^* and *Xrcc1^Nes-Cre^Atm^−/−^* cerebella. Both *Polb^Nes-Cre^Atm^−/−^* and *Xrcc1^Nes-Cre^Atm^−/−^* animals displayed severe ataxia. The expressions of ITPR1 and CAR8 in the cerebral cortex were barely detected. The protein levels of indicated proteins were measured using ImageJ (densitometry) and were normalized to those of tubulin (E). *N* = 3. All bars indicate mean ± SEM; \*\*, *P* \< 0.01.](gkaa140fig4){#F4}

ITPR1 immunoreactivity, found exclusively in the Purkinje cell bodies aligned as a single cell layer and their axons in the molecular layer, was drastically diminished in the *Polb^Nes-Cre^Atm^−/−^* cerebella, even though the Purkinje cell layer was intact in these animals (Figures [2E](#F2){ref-type="fig"} and [4C](#F4){ref-type="fig"}). This reduction of ITPR1 protein was confirmed by western blotting, which also included the *Xrcc1^Nes-Cre^* and *Xrcc1^Nes-Cre^Atm^−/−^* brains to evaluate any difference between *Polb* and *Xrcc1* deficiency in the *Atm* null nervous system, since both double knockout animal models displayed severe ataxia (Figure [4D](#F4){ref-type="fig"} and [E](#F4){ref-type="fig"}). Remarkably, the reduction of ITPR1 was evident in both *Polb^Nes-Cre^Atm^−/−^* and *Xrcc1^Nes-Cre^Atm^−/−^* cerebella, but not in the cerebral cortices of these double knockout animals (Figure [4D](#F4){ref-type="fig"} and [E](#F4){ref-type="fig"}). These data revealed that the ITPR1 reduction was restricted to the cerebellum, particularly to Purkinje cells, as no loss was detected in the double knockout cerebral cortex. Reduction of *Itpr1* expression likely occurs in a progressive manner, since no reduction was observed in the *Polb^Nes-Cre^Atm^−/−^* cerebella at the early stage of postnatal development (Figure [4D](#F4){ref-type="fig"} and [E](#F4){ref-type="fig"}; [Supplementary Figure S4A and B](#sup1){ref-type="supplementary-material"}). The expression levels of ITPR2 and ITPR3 were similar in the cerebral cortices and cerebella of all analyzed animals, suggesting that there was no compensation by other ITPR family proteins for ITPR1 reduction in the double knockout cerebella (Figure [4D](#F4){ref-type="fig"} and [E](#F4){ref-type="fig"}; [Supplementary Figure S4A and B](#sup1){ref-type="supplementary-material"}). In addition, there was a minor reduction of CAR8 detected in the *Polb^Nes-Cre^Atm^−/−^* cerebella, which is expressed in Purkinje cells and can bind to ITPR1 (Figure [4C](#F4){ref-type="fig"}--[E](#F4){ref-type="fig"}) ([@B33]). Aged *Polb^Nes-Cre^* and *Atm^−/−^* animals did not exhibit reduced cerebellar ITPR1 levels ([Supplementary Figure S4C and D](#sup1){ref-type="supplementary-material"}), suggesting that the reduction of ITPR1 in the cerebellum is restricted to a certain physiological condition. As *ITPR1* mutations have clinical relevance for cerebellar ataxia (Figure [4A](#F4){ref-type="fig"}) ([@B19],[@B20],[@B34],[@B35]), reduced expression of *ITPR1* in the cerebellum is likely one of contributing factors toward progressive cerebellar ataxia in human disorders with genomic instability.

Altered cytosine methylation could result in *Itpr1* reduction in the *Polb/Atm* and *Xrcc1/Atm* double knockout cerebella {#SEC3-4}
--------------------------------------------------------------------------------------------------------------------------

We next examined DNA methylation as a potential mechanism for reduced *Itpr1* expression in the double knockout cerebella. Gene expression correlates inversely with 5-methylcytosine (5mC) levels, whose methyl groups are transferred by DNA methyltransferases including DNMT1, DNMT3a and DNMT3b. And it positively correlates with levels of 5-hydroxymethylcytosine (5hmC) which is converted from 5mC by methylcytosine dioxygenase members of the ten-eleven translocation (TET) family. Eventually, modified cytosine bases are corrected by demethylation processes in which BER is involved, thereby influencing gene expression (Figure [5A](#F5){ref-type="fig"}) ([@B18],[@B36]). Furthermore, ATM regulates both the activity of TET1 in response to DNA damage in the cerebellum ([@B37]) and the stability of DNMT1 ([@B38]).

![Epigenetic regulation likely contributes to *Itpr1* reduction in the *Polb^Nes-Cre^Atm^−/−^* and *Xrcc1^Nes-Cre^Atm^−/−^* cerebella. (**A**) Simplified diagram of DNA methylation cycle. Cytosine in DNA is methylated by DNMTs (DNA methyltransferases) to become 5mC (5-methylcytosine), whose levels are inversely correlated with gene expression. 5mC is oxidized by TETs (Ten-eleven translocation methylcytosine dioxygenases), into 5hmC (5-hydroxymethylcytosine). This chemically modified cytosine is recognized for base excision repair (BER) (POLB and XRCC1 are involved) and then is eventually restored to cytosine. Thus, BER participates in the regulation of gene expression. (**B**) The repetitive 5hmC reads and locations on the *Itpr1* gene on chromosome (Chr) 6 from the reduced representation hydroxymethylation profiling (RRHP) analyses. The total reads of 5hmC (\>4 reads) in the 5′ (108,185,000 --108,213,082 \[promoter, magnified\]), *Itpr1* gene (108,213,083--108,551,116) and 3′ (108,551,117--108,555,600) regions were calculated. In the magnified portion, two plots (in black and green) were overlaid for each genetic background, and the vertical lines indicate the locations of 5hmC and the amounts of repetitive reads. The blue arrows indicate one of several 5hmC sites that were reduced in both *Polb^Nes-Cre^Atm^−/−^* and *Xrcc1^Nes-Cre^Atm^−/−^* cerebella. In the graphs, all bars for total 5hmC reads in the marked regions indicate mean ± SEM; \*\*, *P* \< 0.01; \*, *P* \< 0.05. (**C** and **D**) DNMT1 (C) and TET1 (D) enzyme activities in the cerebral cortices and cerebella of mice from six different genetic backgrounds at 3 weeks of age. Chemiluminescence readings for enzyme activity in triplicates (repeated twice) were normalized by protein quantity. There is less enzyme activity of TET1 detected in both *Polb^Nes-Cre^Atm^−/−^* and *Xrcc1^Nes-Cre^Atm^−/−^* cerebella, than in the other genetic backgrounds. *N* = 4 each (all genetic backgrounds). All bars indicate mean ± SEM; \*\*, *P* \< 0.01; NS, not significant. (**E**) Immunohistochemical analyses of 5mC, 5hmC and TET1 with ITPR1 immunoreactivity as well as DNA damage visualized by nuclear γ-H2AX foci in Purkinje cells (calbindin positive) of the cerebellum (sagittal and coronal planes). TET1 is strongly expressed and localized in the nuclei of the Purkinje cells. Similarly strong nuclear 5hmC staining is evident in the Purkinje cells, which showed DNA damage (γ-H2AX foci, yellow arrowheads) only in the *Polb* and *Xrcc1* null cerebellum regardless of the status of *Atm*, and not in the Ctrl and *Atm^−/−^* cerebellum. Nuclear 5mC immunoreactivity was not as robust as that of 5hmC in the Purkinje cells. Reduced ITPR1 immunoreactivity in the *Xrcc1^Nes-Cre^Atm^−/−^* cerebellum is apparent. Mo, Molecular layer; Pur, Purkinje cell layer; Gr, Granule cell layer.](gkaa140fig5){#F5}

First, we compared the global status of genes in the mutant cerebella with those in wild-type cerebella to identify hyper- or hypomethylated genes in each genetic background using two-color CpG Island Microarray technology (Agilent). A number of genes were differentially methylated at CpG Islands in the double knockout cerebella, but various data-mining analyses of these genes did not reveal any close correlation to cerebellar ataxia in humans ([Supplementary Figures S4E and S5A](#sup1){ref-type="supplementary-material"}). As *Itpr1* was not present on this particular CpG microarray for the mouse, pyrosequencing was performed to measure the methylation levels of the *Itpr1* promotor regions in the cerebral cortices and cerebella of all six genetic strains including both double knockout animals. Due to technical limitations, only two promoter regions of the *Itpr1* gene were applicable for pyrosequencing, and the methylation levels were similar among all samples ([Supplementary Figure S5B and C](#sup1){ref-type="supplementary-material"}).

Reduced Representation Hydroxymethylation Profiling (RRHP) technology ([@B23]) was then applied to analyze 5hmC sites and levels at single-base resolution throughout the whole genome from the cerebellar samples of control and knockout animals. The overall coverage of genic 5hmC reads by the RRHP analysis did not differ in all six genetic strains including both double knockout animals ([Supplementary Figure S6B](#sup1){ref-type="supplementary-material"}). In addition, ELISA measurements of DNA samples from the cerebral cortices and cerebella of all examined animal models showed comparable levels of 5mC and 5hmC, with the exception of a minor reduction of the 5mC level in the *Xrcc1^Nes-Cre^Atm^−/−^* cerebellum ([Supplementary Figure S6A](#sup1){ref-type="supplementary-material"}). Nevertheless, the RRHP analysis revealed reduced 5hmC levels at a few genes in both *Polb^Nes-Cre^Atm^−/−^* and *Xrcc1^Nes-Cre^Atm^−/−^* cerebella compared with those in the controls ([Supplementary Figure S7A](#sup1){ref-type="supplementary-material"}). Among these genes, *Itpr1* and Calmodulin-binding transcription activator 1 (*Camta1*) are related to cerebellar ataxia in humans, yet mutations in *CAMTA1* cause non-progressive ataxia in humans ([@B39]). Apparently, *Itpr1* was most specific for the cerebellum among these genes from the RRHP and gene ontology analyses using the Bgee DB ([Supplementary Figure S7B](#sup1){ref-type="supplementary-material"}). The sites of 5hmCs in the *Itpr1* gene region were identical in all the genetic backgrounds studied, and there were no aberrations found in the DNA sequences of the *Itpr1* gene, except for few single nucleotide polymorphisms, in all DNA samples ([Supplementary Figure S6C and D](#sup1){ref-type="supplementary-material"}). However, the repetition of 5hmC reads presented as the height of the bars in the figures, particularly in the promoter region, of the *Itpr1* gene was reduced in the cerebella of the *Polb^Nes-Cre^Atm^−/−^* and *Xrcc1^Nes-Cre^Atm^−/−^* animals compared with that in the cerebellar samples from other genetic backgrounds (Figure [5B](#F5){ref-type="fig"}; [Supplementary Figure S6C](#sup1){ref-type="supplementary-material"}), suggesting that misregulation of cytosine methylation may be responsible in part for the reduced *Itpr1* gene expression.

Next we examined the status of DNA methyltransferases and methylcytosine dioxygenases related to cytosine modification. First, as ATM could interact physically with DNMT1 and regulate its stability ([@B38]), we measured the protein levels of DNMT1 as well as DNMT3a and DNMT3b by western blotting. The expression levels of these enzymes in the cerebral cortex and cerebellum did not differ between double knockout and control animals ([Supplementary Figure S7C--F](#sup1){ref-type="supplementary-material"}). Also the brains from aged *Polb^Nes-Cre^* and *Atm^−/−^* animals did not show any significant change and difference in the expression of these methyltransferases compared with controls ([Supplementary Figure S7G and H](#sup1){ref-type="supplementary-material"}). We further measured the enzyme activity of DNMT1 in cortical and cerebellar samples, which did not differ in all examined animal models (Figure [5C](#F5){ref-type="fig"}). By contrast, the enzyme activity of TET1 was reduced in cerebella, but not cerebral cortices, of *Polb^Nes-Cre^Atm^−/−^* and *Xrcc1^Nes-Cre^Atm^−/−^* animals, likely reflecting the reduced 5hmC levels for *Itpr1* in the double knockout cerebella (Figure [5D](#F5){ref-type="fig"}). Previously, it has been demonstrated that the enzyme activation of TET1 is under the control of ATM upon DNA damage, thereby affecting 5hmC levels ([@B37]). TET1 and 5hmC immunoreactivity was found in the nuclei of Purkinje cells. And DNA damage as visualized by γ-H2AX foci was observed only in animals deficient in DNA damage repair regardless of the presence of *Atm* (Figure [5E](#F5){ref-type="fig"}), suggesting that *Polb^Nes-Cre^* and *Xrcc1^Nes-Cre^* Purkinje cells are chronically exposed to genotoxic stress, which likely acts as one of contributing factors to cerebellar ataxia in an *Atm* deficient condition. Similarly to the *Polb^Nes-Cre^Atm^−/−^* cerebella, ITPR1 immunopositivity was rarely spotted in disarrayed Purkinje cells of the *Xrcc1^Nes-Cre^Atm^−/−^* cerebella (Figure [5E](#F5){ref-type="fig"}).

DISCUSSION {#SEC4}
==========

As demonstrated in several animal models ([@B7],[@B11],[@B27]), endogenous DNA damage occurs during brain development, and defective responses to this kind of damage result in various genetic disorders associated with neurological phenotypes, including progressive cerebellar ataxia ([@B1],[@B2],[@B4]). In patients with A-T, it has been known that neurodegeneration of Purkinje and granule cells in the cerebellum is the main cause for ataxia ([@B1],[@B40]), yet the molecular details of this pathological process are not fully understood. A number of animal models have been generated and studied to explore the underlying molecular mechanisms of A-T etiology ([@B41],[@B42]). Even though *Atm* mutant animal models recapitulate extra-neural phenotypes of A-T, such as immunodeficiency, increased risk to develop cancer, radiosensitivity, but none of A-T animal models display a genuine cerebellar ataxic phenotype in a progressive manner related to A-T syndrome ([@B41],[@B42]). Indeed, the *Atm* knockout animal model used for the current study did not show any sign of cerebellar ataxia and other neurological phenotypes, yet *Atm* null neurons are resistant to induced DNA damage ([@B27],[@B43],[@B44]). Perhaps, an additional genetic impetus may be required to induce ataxia in this *Atm* null animal model. For example, *Xrcc1* deficiency in the nervous system of the *Atm* null animal model induces severe ataxia resulting from developmental defects and malformation of the cerebellum ([@B13]). Nevertheless, this model does not accurately reflect progressive cerebellar ataxia manifested in A-T patients.

Here, we introduce a new animal model with double inactivation of *Polb* and *Atm* in the nervous system that exhibits severe ataxia without developmental and anatomical defects in the cerebellum. While *Xrcc1* inactivation during neurogenesis selectively affects cerebellar interneuron populations by arresting the cell cycle in interneuron progenitors, and produces abnormal hippocampal activity correlated with sporadic seizures ([@B7]), *Polb* inactivation by itself in the nervous system selectively reduced cortical interneurons in the absence of behavioral and cerebellar abnormalities, despite the fact that XRCC1 and POLB work coordinately for base damage repair ([@B9],[@B17]). The different neurophenotypes resulting from *Polb* and *Xrcc1* inactivation might be influenced by redundant or compensatory functions from other DNA polymerases taking part in BER, such as DNA polymerase delta, epsilon and lambda ([@B17],[@B45]). However, their exclusive roles in the nervous system have not yet been explored. Apparently, other XRCC1 binding proteins, such as LIG3, TDP1, PNKP and APEX1, play their distinct roles during neurogenesis and brain function, different from those of XRCC1 ([@B11],[@B13],[@B46]). Nevertheless, *Polb* inactivation in the brain resulted in chronic DNA damage, particularly in the cerebellum, evidenced by ATM phosphorylation, γ-H2AX foci formation, and dense glial fibrillary acidic protein (GFAP) immunoreactivity. Genomic instability in the *Polb* null cerebellum was manifested as medulloblastoma formation, the most common pediatric brain tumor mainly located in the cerebellum, in *p53* deficiency ([@B47]), similarly as in other animal models of genomic instability in a *p53* null background ([@B7],[@B14],[@B48]).

*Atm* deficiency in the cerebellum in conjunction with chronic DNA damage from *Polb* inactivation led to severe cerebellar ataxia without apparent neuropathological defects and to reduced *Itpr1* expression in Purkinje cells. Reduced *Itpr1* expression was also observed in the cerebella of ataxic *Xrcc1* and *Atm* double null animals, suggesting that *Itpr1* reduction in the cerebellum may be one of contributing factors to cerebellar ataxia resulting from genomic instability. The main function of ITPR1, expressed exclusively in Purkinje cells which are rich with calcium binding proteins, such as calbindin and parvalbumin, is to release calcium from the endoplasmic reticulum ([@B33],[@B51],[@B52]). Purkinje cells integrate the large number of neural input signals from various cerebellar interneurons, parallel fibers and climbing fibers to coordinate motor movements (Figue [6](#F6){ref-type="fig"}). As calcium balance is critical for maturation and normal function of Purkinje cells, a disturbance of calcium homeostasis in the cerebellum eventually leads to ataxia ([@B33],[@B53],[@B54]). Accordingly, *ITPR1* mutations are implicated in human genetic diseases with progressive ataxia such as Spinocerebellar ataxia 15/29 and Gillespie syndrome, for which cerebellar ataxia and aberrant calcium spikes in Purkinje cells have been demonstrated in animal models for *Itpr1* mutations ([@B19],[@B33],[@B55]).

![Schematic diagram showing the consequences of genomic instability resulting from defective BER and ATM deficiency in the cerebellum leading to ataxia. The cerebellum, which is located at the back of the brain and is involved in the coordination of motor movement, comprises distinct cellular layers: the molecular layer, Purkinje layer and granule cell layer. Purkinje cell axons transmit inhibitory signals (−) to the deep cerebellar nucleus while integrating inhibitory inputs (−) from interneurons (Stellate and Basket cells) in the molecular layer and excitatory inputs (+) from Granule cells which are under the inhibitory control (−) of Golgi cells in the granule cell layer, as well as (+) inputs from the climbing fibers (not shown). As the only neuronal output is from the Purkinje cells, their dysfunction leads to abnormal coordination of movement (ataxia). Improper responses to chronic DNA damage in the cerebellum due to faulty base excision repair (BER) and ATM dysfunction likely result in various defects, including aberrant DNA methylation and consequently reduced *ITPR1* expression in Purkinje cells. ITPR1 is involved in homeostatic control of Ca~2~^+^ levels necessary for normal Purkinje cell function ([@B54]). This physiological condition might be one of contributing factors to cerebellar ataxia resulting from genomic instability.](gkaa140fig6){#F6}

Interestingly, the cerebella from A-T patients showed differential alteration of the 5mC and 5hmC levels in gene loci compared to normal cerebella, which was not noticeable in the A-T cerebral cortices, and *ITPR1* was one of genes altered substantially in the A-T cerebella ([@B37]), though it is not clear if this is a cause or consequence of Purkinje cell neurodegeneration in A-T patients. In addition, the expression of *ITPR1* was reduced in cerebellar neurons derived from A-T patient specific induced pluripotent stem cells, compared with that of normal controls ([@B56]). The analyses of cerebrospinal fluid from A-T patients and cerebellar transcripts from *Atm^−/−^* animals suggested calcium homeostasis is one of affected physiological conditions in the *ATM* null cerebellum ([@B57]). Furthermore, it has been proposed that an impairment of calcium homeostasis may be predegenerative lesions to Purkinje cell degeneration in A-T patients, as progressive calcium deficits were observed in the Purkinje cells of another *Atm* null animal model ([@B58]).

The Purkinje cell layer is vulnerable to a diversity of genetic insults ([@B1],[@B53]), and these cells exhibit a highly dynamic cycle of cytosine demethylation and remethylation, which can influence gene expression ([@B59]). Given the previous demonstrations that *Polb*-dependent BER is necessary for DNA demethylation in the nervous system ([@B60]), and that ATM controls TET1 enzyme activity, which converts 5mC to 5hmC, in the cerebellum upon DNA damage ([@B37]), our data suggest that a misregulation of cytosine methylation in the *Itpr1* gene caused in part by diminished TET1 enzyme activity results in reduced *Itpr1* expression in the cerebellum, leading to the neuronal vulnerability associated with cerebellar ataxia. Thus, *Atm* deficiency likely contributes to reduced *Itpr1* expression in the cerebellum under a condition of chronic DNA damage.

As illustrated in Figure [6](#F6){ref-type="fig"}, ATM and BER are necessary for proper cerebellar function. Defective BER in association with *Atm* deficiency in the cerebellum results in chronic DNA damage that leads to cerebellar ataxia, in part by reducing *Itpr1* expression in connection with epigenetic misregulation. The findings presented here contribute another piece to the large puzzle of how cerebellar ataxia is initiated and how it progresses in human patients with genomic instability. Cerebellar ataxia resulting from genomic instability cannot be explained by one or two regulatory mechanisms. The various molecular mechanisms should be involved in the progression of cerebellar ataxia, as exemplified by the diverse functions of ATM to maintain cellular homeostasis ([@B41]). Perhaps ITPR1 reduction is one of common denominators in the prodromal phase of progressive cerebellar ataxia in various genomic instability disorders. Further analyses of the double knockout animal model with extended lifespans as a result of additional genetic modification or pharmacological intervention for calcium homeostasis will help us to examine in greater detail the neurodegenerative attributes and underlying mechanisms related to ataxia in the *Polb* and *Atm* double null cerebellum.
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